Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Challenging clinical cases in HCV infection.
Strazzulla A, Matera G, Mammone SV, Vaccaro V, Pisani V, Costa C, Manti F, Doldo P, Cosco L, Quintieri F, Cesario F, Liberto MC, Giancotti A, Torti C, Focà A. Strazzulla A, et al. Among authors: vaccaro v. BMC Infect Dis. 2014;14 Suppl 5(Suppl 5):S7. doi: 10.1186/1471-2334-14-S5-S7. Epub 2014 Sep 5. BMC Infect Dis. 2014. PMID: 25236848 Free PMC article.
Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience.
Dattilo G, Bitto R, Correale M, Morabito C, Vaccaro V, Laterra G, Casale M, Crea P, DI Bella G, Luzza F, Migliorato A, Katsiki N, DE Gregorio C. Dattilo G, et al. Among authors: vaccaro v. Minerva Cardiol Angiol. 2022 Oct;70(5):555-562. doi: 10.23736/S2724-5683.20.05494-8. Epub 2021 Apr 7. Minerva Cardiol Angiol. 2022. PMID: 33823573
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.
Dattilo G, Laterra G, Licordari R, Parisi F, Pistelli L, Colarusso L, Zappia L, Vaccaro V, Demurtas E, Allegra M, Crea P, Di Bella G, Signorelli SS, Aspromonte N, Imbalzano E, Correale M. Dattilo G, et al. Among authors: vaccaro v. J Clin Med. 2023 Sep 28;12(19):6247. doi: 10.3390/jcm12196247. J Clin Med. 2023. PMID: 37834892 Free PMC article.
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment.
Giordano G, Milella M, Landriscina M, Bergamo F, Tirino G, Santaniello A, Zaniboni A, Vasile E, De Vita F, Re GL, Vaccaro V, Giommoni E, Natale D, Conca R, Santini D, Maiorino L, Sanna G, Ricci V, Iop A, Montesarchio V, Procaccio L, Noventa S, Bianco R, Febbraro A, Lonardi S, Tortora G, Sperduti I, Melisi D. Giordano G, et al. Among authors: vaccaro v. Cancer Med. 2024 Jun;13(12):e7345. doi: 10.1002/cam4.7345. Cancer Med. 2024. PMID: 38924262 Free PMC article.
106 results